Literature DB >> 26501213

A Simple Derived Prediction Score for the Identification of an Elevated Pulmonary Artery Wedge Pressure Using Precatheterization Clinical Data in Patients Referred to a Pulmonary Hypertension Center.

Stefan E Richter1, Kari E Roberts2, Ioana R Preston2, Nicholas S Hill2.   

Abstract

BACKGROUND: One of the foremost diagnostic challenges in clinical pulmonary hypertension is discriminating between pulmonary arterial hypertension (group 1) and heart failure with preserved ejection fraction (group 2.2). Group 2.2 is defined as a normal left ventricular ejection fraction (> 50%) and a pulmonary arterial wedge pressure (PAWP) > 15 mm Hg. We aimed to determine whether patient history, demographics, and noninvasive measures could predict PAWP before to right heart catheterization.
METHODS: Data were prospectively collected on 350 consecutive patients at a single tertiary care medical center; of these patients, 151 met criteria for entry into our study (88 in group 1 and 63 in group 2.2). Data included historical features, demographics, and results of a transthoracic echocardiogram. A multivariate regression model was developed to predict PAWP > 15 mm Hg.
RESULTS: Univariate predictors of PAWP > 15 mm Hg included older age, higher BMI and weight, systemic systolic BP and pulse pressure, more features of the metabolic syndrome, presence of hypertension and left atrial enlargement, absence of right ventricular enlargement, and lower glomerular filtration rate and 6-min walk distance. The optimal model for predicting PAWP > 15 mm Hg was composed of age (> 68 years), BMI (> 30 kg/m(2)), absence of right ventricular enlargement, and presence of left atrial enlargement (area under the curve, 0.779).
CONCLUSIONS: Clinical characteristics obtained before diagnostic right heart catheterization accurately predict the probability of elevation of PAWP > 15 mm Hg in patients with preserved ejection fraction. These combined clinical characteristics can be used a priori to predict the likelihood of group 2.2 pulmonary hypertension.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  epidemiology (pulmonary); heart failure; pulmonary arterial hypertension; research-clinical

Mesh:

Year:  2016        PMID: 26501213     DOI: 10.1378/chest.15-0819

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Prediction of pulmonary hypertension in older adults based on vital capacity and systolic pulmonary artery pressure.

Authors:  Simon Wernhart; Jürgen Hedderich
Journal:  JRSM Cardiovasc Dis       Date:  2020-11-12

Review 2.  Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Athanasios Charalampopoulos; Robert Lewis; Peter Hickey; Charlotte Durrington; Charlie Elliot; Robin Condliffe; Ian Sabroe; David G Kiely
Journal:  Front Med (Lausanne)       Date:  2018-06-06

3.  Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland.

Authors:  Harrison Stubbs; Alexander MacLellan; Michael McGettrick; Bhautesh Jani; Melanie Brewis; Colin Church; Martin Johnson
Journal:  Open Heart       Date:  2022-04

4.  Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score.

Authors:  Samara M A Jansen; Anna E Huis In 't Veld; Wouter Jacobs; Hans P Grotjohan; Marc Waskowsky; Jan van der Maten; Arno van der Weerdt; Romke Hoekstra; Maria J Overbeek; Sjoerd A Mollema; Peter Hans C G Tolen; Lahssan H Hassan El Bouazzaoui; Joris W J Vriend; J Milena M Roorda; Ramon de Nooijer; Ivo van der Lee; Bart A J Voogel; Kathinka Peels; Thomas Macken; Jacqueline M Aerts; Anton Vonk Noordegraaf; M Louis Handoko; Frances S de Man; Harm Jan Bogaard
Journal:  J Am Heart Assoc       Date:  2020-07-31       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.